Enlarged Prostate on CT or MRI: What It Means

Seeing “enlarged prostate” on a CT or MRI report

Reading that the prostate is “enlarged,” “heterogeneous,” “nodular,” or “indenting the bladder base” can be worrying. Many people immediately wonder: Is this cancer? Could it explain my weak stream or incomplete emptying? Do I need PSA testing, PI-RADS scoring, or a urology visit?

This article is general education, not a diagnosis. Imaging findings must be interpreted with your symptoms, exam, PSA history, urine tests, prior imaging, and the official radiology report.

An enlarged prostate on imaging is common and often reflects benign prostatic hyperplasia, or BPH, but CT or MRI findings should not be interpreted in isolation.

What is BPH?

Benign prostatic hyperplasia, often called BPH, means non-cancerous enlargement of the prostate gland. The prostate sits just below the bladder and surrounds the first part of the urethra, the tube that carries urine out of the body. As the prostate enlarges, it can press on the bladder outlet or urethra.

BPH is not prostate cancer. However, BPH and prostate cancer can both occur in the prostate, and symptoms can overlap. That is why urologists usually look at the whole picture rather than one phrase in an imaging report.

How BPH can look on CT or MRI

CT and MRI reports may describe BPH in different ways. Common wording includes:

• Prostatomegaly: a medical word for enlarged prostate.
• Heterogeneous or nodular prostate: uneven texture, often related to nodules in the central or transition zone of the prostate.
• Median lobe enlargement: a central part of the prostate bulges upward toward the bladder.
• Bladder-base indentation or mass effect: the enlarged prostate pushes into the bottom of the bladder.
• Intravesical protrusion: prostate tissue projects into the bladder space.

On a routine abdomen or pelvis CT, the prostate can be measured and its effect on the bladder can be seen, but CT is not the best test for finding small prostate cancers. A dedicated prostate MRI gives much more detail, especially when it includes T2 images, diffusion imaging, and contrast sequences.

Why MRI is not read by itself: PSA, PI-RADS, and symptoms matter

A dedicated prostate MRI may include a PI-RADS score. PI-RADS is a standardized system radiologists use to describe how suspicious a prostate MRI finding looks for clinically significant prostate cancer. A lower score is generally less suspicious, and a higher score is more suspicious. The score is based on the appearance of the prostate across multiple MRI sequences, not just one image.

Still, PI-RADS is only one part of decision-making. A urologist may also consider:

• PSA level and PSA trend over time.
• PSA density, which relates PSA to prostate size.
• Digital rectal exam findings.
• Family history and prior biopsy results, if any.
• Urinary symptoms and whether they fit bladder outlet obstruction.

PSA can rise for several reasons, including BPH, inflammation or infection of the prostate, recent urinary retention, recent procedures, and prostate cancer. A single PSA number usually needs context.

Urinary symptoms people often discuss with urology

An enlarged prostate can affect urination in different ways. Urologists often group these as lower urinary tract symptoms, or LUTS.

Voiding symptoms

• Weak urine stream
• Hesitation before urine starts
• Stopping and starting
• Straining to urinate
• Taking a long time to empty

Storage symptoms

• Frequent urination
• Urgency
• Waking at night to urinate
• Leaking before reaching the bathroom

After-urination symptoms

• Feeling of incomplete emptying
• Dribbling after urination
• Needing to go again soon after finishing

These symptoms can come from BPH, but they can also be related to bladder muscle function, urinary tract infection, medications, neurologic conditions, diabetes, stones, or other causes. That is why symptom review is often paired with urine testing and bladder emptying measurements.

What bladder findings may mean

Some CT or MRI reports mention a trabeculated bladder wall, mild bladder wall thickening, or a very full bladder. Trabeculation means the bladder wall looks somewhat ridged or thickened. In the setting of an enlarged prostate, this can suggest the bladder has worked against resistance for a long time.

However, bladder wall appearance depends on how full the bladder was during the scan. A nearly empty bladder can look thicker than it truly is. Infection, inflammation, prior procedures, radiation, bladder stones, and bladder tumors can also affect the bladder wall.

If a report raises concern about the bladder, or if there is blood in the urine, doctors may consider tests such as urinalysis, urine culture, urine cytology in selected cases, ultrasound measurement of post-void residual, uroflowmetry, or cystoscopy. Cystoscopy is a camera exam of the bladder and urethra and is often better than CT or prostate MRI for directly inspecting the bladder lining.

What about seminal vesicles, epididymis, and small glands?

People sometimes notice comments about the seminal vesicles on prostate MRI. These paired glands sit behind the prostate and contribute fluid to semen. In prostate cancer staging, radiologists look for signs that a tumor has invaded the seminal vesicles.

Size or volume differences between the right and left seminal vesicles can occur for many reasons and are often nonspecific. Seminal vesicle size alone usually cannot diagnose blockage of the epididymis. The epididymis is in the scrotum, so scrotal symptoms are usually evaluated with a physical exam and scrotal ultrasound rather than prostate MRI.

The bulbourethral glands are small glands near the base of the penis. They are not always clearly assessed on routine prostate MRI, and they are not usually the focus of BPH or PI-RADS interpretation.

If the report mentions bone spots

Some imaging reports describe dense or sclerotic spots in bones. Many bone spots are benign, such as bone islands, but in certain contexts radiologists and doctors may consider metastatic disease, including from prostate cancer. This is especially important when bone findings are multiple, new, or paired with a concerning PSA or cancer history.

Follow-up may involve comparison with older imaging, PSA testing, targeted MRI, bone scan, PET/CT, PSMA PET/CT, or specialist review. The right next test depends on the official radiology interpretation and clinical context.

Questions to bring to your clinician

• Does the imaging appearance fit BPH, and how large is the prostate?
• Is there a median lobe protruding into the bladder?
• Was a PI-RADS score assigned on the official prostate MRI report?
• How do my PSA level and PSA trend fit with the imaging?
• Do I have measurable urine left in the bladder after voiding?
• Do bladder wall changes need urine testing, ultrasound, or cystoscopy?
• If bone spots were mentioned, are they benign-appearing or do they need further workup?

When to talk to your doctor

Talk with your doctor or a urologist if your report mentions prostate enlargement and you have weak stream, urgency, nighttime urination, incomplete emptying, elevated or rising PSA, blood in the urine, recurrent urinary infections, or bladder wall changes. Seek prompt medical care for inability to urinate, fever with urinary symptoms, severe pelvic or back pain, new leg weakness or numbness, or loss of bladder or bowel control.